Oral Abstract Session:
120. Antimicrobial Resistance and Susceptibility
Saturday, October 22, 2011: 10:15 AM-11:45 AM
Room: 151AB

Topical Category: A. Antimicrobial agents and Resistance

Tracks: Adult ID, Pediatric ID

Moderators:  Mini Kamboj, MD, Memorial Sloan-Kettering Cancer Ctr. and George Eliopoulos, MD, FIDSA, Beth Israel Deaconess Medical Center, Harvard Medical School

Presentations:

10:15 AM
870
Factors Influencing Time to Resolution of Diarrhea (TTROD) in Patients with Clostridium difficile Infection (CDI) Treated with Fidaxomicin (FDX) or Vancomycin (VAN)
Derrick Crook, MB BCh ; Mark Miller, MD, MSc ; Thomas Louie, M D ; Oliver Cornely, MD, FIDSA ; Tim Peto, MB BS, DPhil ; Dale Gerding, MD, FIDSA ; Sherwood Gorbach, MD, FIDSA

10:30 AM
871
A Study of Genetic and Functional Alterations in Enterococcus Faecium Resistant to Daptomycin
Spiros Miyakis ; Oriol Gasch ; Joanna Dakos ; Robert Moellering, Jr Jr., MD, FIDSA ; George Eliopoulos, MD, FIDSA

10:45 AM
872
Differences in Neisseria gonorrhoeae Antibiotic Susceptibility among Men by Sex of Sex Partner, United States, 2005–2010
Robert D. Kirkcaldy, MD, MPH ; Carlos del Rio, MD ; Geraldine Hall, PhD ; King Holmes, MD, PhD, FIDSA ; Edward Hook, MD ; Olusegun Soge, PhD ; John Papp, PhD ; Hillard Weinstock, MD, MPH

11:00 AM
873

11:15 AM
874
Does minimum inhibitory concentration mediate the relationship between causative organism and clinical outcome in bacterial keratitis?
Catherine Oldenburg, MPH ; Lalitha Prajna, MD ; Muthiah Srinivasan, MD ; Jeena Mascarenhas, MD ; Kathryn Ray, MA ; David Glidden, PhD ; Nisha Acharya, MD, MS ; Thomas Lietman, MD

11:30 AM
875
Optimal Strategy to Identify KPC-Possessing Enterobacteriaceae Using the Updated CLSI Breakpoints
Manisha Singh, MBBS ; Julius Salamera, MD ; David Landman, MD ; John Quale, MD

CME Credits:

ACPE Credits:

ACPE Number:

Disclosures:

M. Kamboj, None

G. Eliopoulos, Antimicrobial Therapy Inc: Editor, Licensing agreement or royalty
Theravance Inc: Research Contractor, Research support

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.